DRIO DarioHealth shares edge higher despite Q4 2025 EPS landing below analyst consensus estimates XOMAP XOMA posts massive Q4 2025 earnings beat but shares fall 144 percent in todays trading Should I sell Burlington BURL stock Burlington delivers 1 percent EPS beat vs analyst consensus estimates US Residential Real Estate Private Listing Industry Dispute Analysis Is Fortress Biotech FBIO stock cheap Q4 2025 EPS Misses Views